Implementing a Multisite Clinical Trial in the Midst of an Ebola Outbreak: Lessons Learned From the Sierra Leone Trial to Introduce a Vaccine Against Ebola

Rosalind J. Carter(Centers for Disease Control and Prevention), Jane F. Seward(Centers for Disease Control and Prevention), Wendy Carr(University of British Columbia), Foday Sahr(Sierra Leone Urban Research Centre), Jennifer Legardy-Williams(Centers for Disease Control and Prevention), Amy Callis(Centers for Disease Control and Prevention), Stephen C. Hadler(The Task Force for Global Health), Stacie M. Greby(Centers for Disease Control and Prevention), Stephanie J. Schrag(Centers for Disease Control and Prevention), Sara Hersey(Centers for Disease Control and Prevention), Mohamed Samai(University of Sierra Leone), Marc‐Alain Widdowson(Centers for Disease Control and Prevention), Marc Fischer(Laboratoire National de Santé), Ayesha Idriss(University of Sierra Leone), Joseph Edem-Hotah(University of Sierra Leone), Amanda Cohn(Computer Emergency Response Team), Winston Webber(University of Sierra Leone), Melvina Thompson, Laura Gibson(University of Massachusetts Chan Medical School), Concepción F. Estívariz(Centers for Disease Control and Prevention), W. M. Mcdonald(Centers for Disease Control and Prevention), Dayo Spencer-Walters(Sierra Leone Urban Research Centre), Julianne Gee, Ahamed Flagbata Kallon(University of Sierra Leone), Joseph Bresee(The Task Force for Global Health), Anne Schuchat(National Center for Injury Prevention and Control), Roselyn M’baindu Momoh(University of Sierra Leone)
The Journal of Infectious Diseases
December 15, 2017
Cited by 31


Related Papers